Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the peptide antibiotics market size evolved in recent years?

In recent years, the peptide antibiotics market has seen a swift expansion. The size of this market is predicted to rise from $5.25 billion in 2024 to $5.82 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.8%. This progression during the historic period can be linked to factors such as the discovery and enhancement of peptide antibiotics, amplified antibiotic resistance, a surge in the number of infectious diseases, advancements in peptide synthesis technologies, and the thriving pharmaceutical industry.

What are the predictions for the peptide antibiotics market size in the coming years?

Expectations are for strong expansion in the peptide antibiotics market over the next few years, with projected growth to $8.47 billion by 2029, representing a compound annual growth rate (CAGR) of 9.8%. This anticipated growth during the forecast period can be attributed to a focus on developing novel antibiotics, a surge in global antibiotic-resistant infections, expansion in antimicrobial peptide research and development, and regulatory support for new antibiotic approvals. Key trends expected during this forecast period include the exploration of natural sources for antimicrobial peptides, utilizing peptide antibiotics for animal health, emphasizing on peptide engineering for improved effectiveness, the creation of combined peptide antibiotics, and the integration of artificial intelligence along with machine learning into peptide antibiotic discovery.

Get your peptide antibiotics market report here!

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

What key factors are fueling the growth of the peptide antibiotics market?

The upward trend in the prevalence of diverse infectious ailments is anticipated to spur the growth of the peptide antibiotics market. These diseases are brought about by harmful pathogens like bacteria, fungi, parasites, and more. Key factors leading to the surge in such diseases include quick urbanization, shifts in the climate, growing risk of disease emergence, among others – all of which bolster the demand for peptide antibiotics. These peptide antibiotics work by breaking the cell membranes, thereby enhancing antibacterial activity. For example, data from the World Health Organization, an intergovernmental organization based in Switzerland, revealed that by May 2024, the count of dengue cases in the Americas had already exceeded seven million in April 2024—a significant increase from the 4.6 million cases in the entirety of 2023. Hence, this rise in infectious disease occurrences is fueling the peptide antibiotics market’s growth.

How is the global peptide antibiotics market divided into key segments?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

Who are the key firms paving the way for growth in the peptide antibiotics market?

Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Which trends are expected to transform the peptide antibiotics market?

A rising trend in the peptide antibiotics market is the strategic alliance between major companies. These corporations are collaborating to broaden their reach and utilize shared resources. For example, in January 2022, Berkeley Lights, an American digital cell biology firm, joined forces with Aanika Biosciences. In this collaboration, Aanika will take advantage of Berkeley Lights’ high-throughput, functional screening service to quickly identify and optimize antimicrobial peptides (AMPs) that can destroy harmful bacteria, especially those linked to foodborne diseases. Additionally, the Beacon Optofluidic Platform will aid in recognizing peptides that are detrimental to bacteria, intending to create a new antibacterial tag. This tag will then be integrated into their bacterial spore-based barcoding technology to ensure food supply chain safety. Aanika Biosciences is a biotech firm based in the United States.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780

What regions are contributing significantly to the growth of the peptide antibiotics market?

North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Anticoagulants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

Multivitamin Capsules And Tablets Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/multivitamin-capsules-and-tablets-global-market-report

Vitamin and Minerals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vitamin-and-mineral-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: